Old Web
English
Sign In
Acemap
>
authorDetail
>
Ayman Al-Shurbaji
Ayman Al-Shurbaji
AstraZeneca
Internal medicine
Sodium zirconium cyclosilicate
Medicine
Urology
Hyperkalemia
3
Papers
58
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
MO214EVALUATION OF THE EFFECT OF A POTASSIUM BINDER ON ARRHYTHMIA-RELATED CARDIOVASCULAR OUTCOMES IN PATIENTS ON CHRONIC HAEMODIALYSIS WITH RECURRENT HYPERKALAEMIA: DESIGN AND RATIONALE FOR THE SODIUM ZIRCONIUM CYCLOSILICATE DIALIZE-OUTCOMES STUDY
2021
Nephrology Dialysis Transplantation
Steven Fishbane
Michel Jadoul
Laura M. Dember
Csaba P. Kovesdy
Ian Sabir
Ayman Al-Shurbaji
Fredrik Thorén
Brian G. Katona
Nicolas Guzman
John Xu
Charles A. Herzog
Show All
Source
Cite
Save
Citations (0)
A Phase 3b, Randomized, Double-Blind, Placebo-Controlled Study of Sodium Zirconium Cyclosilicate for Reducing the Incidence of Predialysis Hyperkalemia
2019
Journal of The American Society of Nephrology
Steven Fishbane
Martin Ford
Masafumi Fukagawa
Kieran McCafferty
Anjay Rastogi
Bruce Spinowitz
Konstantin Staroselskiy
Konstantin Vishnevskiy
Vera Lisovskaja
Ayman Al-Shurbaji
Nicolas Guzman
Sunil Bhandari
Show All
Source
Cite
Save
Citations (45)
Efficacy and Safety of Sodium Zirconium Cyclosilicate for Treatment of Hyperkalemia: An 11-Month Open-Label Extension of HARMONIZE
2019
American Journal of Nephrology
Simon D. Roger
Bruce Spinowitz
Edgar V. Lerma
Bhupinder Singh
David K. Packham
Ayman Al-Shurbaji
Mikhail Kosiborod
Show All
Source
Cite
Save
Citations (13)
1